Search clinical trials for: Pyrotinib, Trastuzumab, Docetaxel
Total 3271 results
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingMetastatic Breast CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Second Affiliated Hospital, School of Medicine,...Zhejiang Cancer Hospital; First Affiliated Hospital of Zhejiang University; Sir... and other collaboratorsUnknownColorectal CancerChina
-
Shandong UniversityUnknownHER2-positive Breast Cancer
-
Peking University Cancer Hospital & InstituteNot yet recruiting
-
Henan Cancer HospitalCompletedHER2 Positive Breast CancerChina
-
The First Affiliated Hospital with Nanjing Medical...Anhui Provincial Cancer Hospital; Affiliated Hospital of Jiangnan University; The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School and other collaboratorsRecruiting
-
Fudan UniversityRecruitingEffect of Drug | Gastrointestinal TumorChina
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruiting
-
xuexin heNot yet recruitingHER2-positive Breast Cancer
-
Huihua XiongNot yet recruiting
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruiting
-
Jiangsu HengRui Medicine Co., Ltd.UnknownHER2 Positive Gastric CancerChina
-
Fudan UniversityCompleted
-
Jonsson Comprehensive Cancer CenterCompletedBreast CancerUnited States
-
Zhejiang Cancer HospitalRecruiting
-
Fudan UniversityRecruiting
-
Cancer Institute and Hospital, Chinese Academy...RecruitingCarcinoma, Transitional Cell | HER-2 Gene AmplificationChina
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingHER2-positive Breast CancerChina
-
Shengjing HospitalNot yet recruiting
-
Fudan UniversityRecruitingMetastatic Breast Cancer | HER2-positive Breast CancerChina
-
Shanghai Changzheng HospitalUnknown
-
Peking UniversityRecruitingHER2-positive Breast CancerChina
-
Henan Cancer HospitalRecruitingBreast Cancer | HER2-positive Breast CancerChina
-
Zhejiang Cancer HospitalUnknownBreast Cancer | Breast Diseases | Neoplasm, BreastChina
-
Youzhi ZhuRecruitingBreast Cancer FemaleChina
-
Shandong Cancer Hospital and InstituteUnknownMetastatic Breast Cancer | HER2-positive Breast Cancer
-
Fujian Medical University Union HospitalRecruiting
-
European Organisation for Research and Treatment...GlaxoSmithKlineCompletedBreast CancerFrance, United Kingdom, Belgium, Switzerland, Slovenia
-
Zhe Jiang Hisun Bioray Bio-pharmaceu tical Co.LtdUnknown
-
Austrian Breast & Colorectal Cancer Study GroupHoffmann-La Roche; CephalonCompleted
-
Finnish Breast Cancer GroupCompleted
-
Caigang LiuJiangsu HengRui Medicine Co., Ltd.Recruiting
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI); Aventis PharmaceuticalsTerminated
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingHER2-positive Breast Cancer | Early-stage Breast Cancer | Adjuvant Treatment After Trastuzumab | RCB Classification 1-2 | NeratiniChina
-
Biocon Biologics UK LtdNot yet recruitingHR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingNon-squamous NSCLC | HER2 Exon 20 MutationKorea, Republic of, United States, Taiwan, Belgium, Spain, China, Australia, Turkey, Italy, France, Germany, Poland, Russian Federation
-
Shandong Cancer Hospital and InstituteUnknownBreast Cancer | HER2-positive Breast CancerChina
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Cancer Trials IrelandCompleted
-
Hebei Medical University Fourth HospitalOrigiMedRecruitingProspective | ObservationalChina
-
Zhejiang Cancer HospitalJiangsu HengRui Medicine Co., Ltd.UnknownMetastatic Breast CancerChina
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Active, not recruiting
-
Samsung Bioepis Co., Ltd.CompletedHER2 Positive Early or Locally Advanced Breast CancerCzechia
-
First Affiliated Hospital of Zhejiang UniversityRecruitingBreast Cancer | HER2-positive Breast Cancer | Estrogen Receptor Positive TumorChina
-
Intergroupe Francophone de Cancerologie ThoraciqueCompletedNon Small Cell Lung Cancer Metastatic | HER2 Gene Mutation | Non Small Cell Lung Cancer Stage IIIFrance
-
King Faisal Specialist Hospital & Research CenterCompleted
-
Thomas HatschekActive, not recruitingEarly-Stage Breast Carcinoma | HER-2 Positive Breast CancerSweden
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu HengRui Medicine Co., Ltd.Recruiting